SenesTech, Inc. filings document the public-company records of a Nasdaq-listed developer of fertility-control products for rodent and animal pest management. Recent Form 8-K reports cover operating results, commercial updates tied to e-commerce and Evolve products, and material governance events involving executive appointments, departures, employment terms, and compensation arrangements.
SenesTech proxy materials describe annual meeting matters, board and executive compensation disclosures, shareholder voting items, and governance information. The filings also identify the company’s registered common stock, par value, trading symbol SNES, and Nasdaq listing, providing formal disclosure around capital structure and corporate administration.
Private investor Justin LeBeau reported beneficial ownership of 294,773 shares of SenesTech, Inc. (SNES) common stock, approximately 5.4% of the class. The percentage is based on 5,423,542 shares outstanding as of August 4, 2026. LeBeau reports sole voting and dispositive power over 64,862 shares and shared voting and dispositive power with his spouse, Laurel Michelle LeBeau, over 229,911 shares held in their joint tenancy brokerage account.
He states the shares were acquired in open-market purchases for an aggregate purchase price of approximately $229,261.57. During the past 60 days, he reported individual-account purchases of 59,862 shares for $52,705.04 and joint-account purchases of 229,911 shares for $168,456.53.
LeBeau says he acquired the shares for investment purposes and may discuss SenesTech's business, expenses, capital allocation, compensation and governance with management, directors and other stockholders. Depending on various factors, he may purchase additional shares, dispose of some or all of his holdings, or formulate proposals.
SenesTech, Inc. (SNES) reported that Glenbrook Capital Management, a 10% owner, purchased common stock indirectly through accounts it manages: 36,375 shares on October 20, 2026, at a weighted average price of $0.6746 per share; 60,000 shares on October 21 at $0.7385 per share; and 7,500 shares on October 22 at $0.7986 per share. After the October 20 purchase, reported holdings were 2,099,473 shares. Glenbrook disclaimed beneficial ownership for Section 16 purposes except to the extent of any pecuniary interest, if any; no Rule 10b5-1 plan is reported.
Glenbrook Capital Management amended its beneficial-ownership report concerning SenesTech, Inc. (SNES), stating it beneficially owns 2,166,973 common shares, or 39.95% of the class. Glenbrook reports shared voting and dispositive power over those shares. The reported percentage is based on 5,423,542 SenesTech shares outstanding as of August 4, 2026.
The amendment states that approximately $4.14 million, excluding brokerage commissions, was paid to acquire the reported securities using general working capital of the Glenbrook Funds and Accounts.
SenesTech, Inc. (SNES) received Nasdaq notice that its closing bid price had remained below $1.00 per share for 30 consecutive business days, so its common stock no longer meets Nasdaq’s minimum bid-price requirement. The notice has no immediate effect on the stock’s Nasdaq Capital Market listing. SenesTech has 180 calendar days, through April 19, 2027, to regain compliance by closing at $1.00 or more for at least 10 consecutive business days.
SenesTech also reported preliminary third-quarter revenue of approximately $1.1 million, described as the highest in company history, up 40% from the second quarter and 55% from the third quarter of 2025. If it does not regain compliance by April 19, 2027, it may be eligible for another 180-calendar-day period if it meets the other applicable initial listing standards and gives written notice of its intention to cure the deficiency.
SenesTech, Inc. (SNES) reported three common-stock purchases by accounts for which Glenbrook Capital Management serves as investment manager: 426,000 shares on October 15, 2026, 181,252 shares on October 16, 2026, and 376,552 shares on October 19, 2026. The reported weighted-average prices were $0.7679, $0.6289, and $0.7036 per share, respectively. The October 15 transaction reported 1,505,294 shares held indirectly following that purchase. Glenbrook disclaimed beneficial ownership except to the extent of any pecuniary interest.
SenesTech, Inc. (SNES) is the issuer in an amended ownership disclosure reporting Glenbrook Capital Management’s beneficial ownership of 2,063,098 common shares, or 38.04% of the class, with shared voting and dispositive power. The percentage is based on 5,423,542 shares outstanding as of August 4, 2026.
Glenbrook says approximately $4.33 million, excluding brokerage commissions, was paid to acquire the securities using general working capital of the Glenbrook Funds and Accounts; its transactions during the prior 60 days were all in the open market. It may discuss board composition and governance with directors, management and others, and may recommend changes, seek to fill vacancies, or propose or nominate director candidates, depending on discussions and other factors. Glenbrook says it has made no specific decision and gives no assurance it will take such action.
SenesTech, Inc. (SNES) reported preliminary third-quarter 2026 revenue of approximately $1.1 million, its highest quarterly revenue and first quarter at or above the $1 million threshold. Revenue was approximately 40% higher than in the second quarter of 2026 and approximately 55% higher than in the third quarter of 2025. The estimate is unaudited, preliminary and subject to adjustment and completion of quarter-end closing procedures; the company plans to release definitive third-quarter results the week of November 9, 2026.
SenesTech said it expects definitive results to reflect continued e-commerce momentum, including higher subscription revenue, and increasing traction in B2B. It said higher subscription revenue is expanding the recurring component of revenue. CEO Michael Edell said e-commerce continues to scale as a controllable, data-driven acquisition engine and the vertical-focused B2B organization is gaining traction. He also said investments and transition costs incurred earlier in the year are increasingly behind the company, and management expects continued, improved metrics going forward.
SenesTech, Inc. (SNES) Chief Executive Officer Michael Edell purchased 2,000 common shares on September 28, 2026, at $0.6444 per share. The shares were held directly, bringing his reported direct holdings to 11,000 shares after the purchase. No Rule 10b5-1 plan is reported.
SenesTech, Inc. (SNES) reported that Chief Executive Officer and director Michael Edell purchased common stock in the company. On September 14, 2026, he bought 1,000 shares of common stock at $0.84 per share in a purchase reported as a direct holding. Following this transaction, he directly owns 9,000 shares of SenesTech common stock. No Rule 10b5-1 trading plan is indicated for this transaction.
SenesTech, Inc. (SNES) reported that Chief Executive Officer and director Michael Edell purchased a total of 2,000 shares of common stock on September 9, 2026 in open-market transactions, with 1,000 shares bought at $0.89 per share and 1,000 shares bought at $0.85 per share. No Rule 10b5-1 trading plan is reported for these purchases.